Hormone Resistant Prostate Cancer Active Not Recruiting Phase 1 / 2 Trials for Enzalutamide (DB08899)

Also known as: Hormone-Resistant Prostate Cancer

IndicationStatusPhase
DBCOND0038482 (Hormone Resistant Prostate Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs